Trade IDEXX Laboratories, Inc. - IDXX CFD
Add to favourite- Summary
- Historical Data
| Spread | 1.96 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023346% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001124% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 0.1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 428.33 |
| Open | 423.98 |
| 1-Year Change | -18.44% |
| Day's Range | 417.52 - 426.43 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Jan 16, 2025 | 428.33 | 8.64 | 2.06% | 419.69 | 429.24 | 414.62 |
| Jan 15, 2025 | 422.66 | 2.43 | 0.58% | 420.23 | 429.37 | 418.95 |
| Jan 14, 2025 | 416.91 | -2.99 | -0.71% | 419.90 | 423.41 | 412.10 |
| Jan 13, 2025 | 421.19 | 7.56 | 1.83% | 413.63 | 423.82 | 410.55 |
| Jan 10, 2025 | 416.33 | -9.54 | -2.24% | 425.87 | 428.93 | 416.33 |
| Jan 8, 2025 | 430.77 | 6.82 | 1.61% | 423.95 | 437.14 | 419.44 |
| Jan 7, 2025 | 425.75 | -1.21 | -0.28% | 426.96 | 434.48 | 423.21 |
| Jan 6, 2025 | 427.42 | 15.28 | 3.71% | 412.14 | 434.71 | 410.50 |
| Jan 3, 2025 | 414.25 | 6.30 | 1.54% | 407.95 | 417.01 | 405.43 |
| Jan 2, 2025 | 408.68 | -6.26 | -1.51% | 414.94 | 418.87 | 406.32 |
| Dec 31, 2024 | 411.99 | -2.88 | -0.69% | 414.87 | 417.55 | 410.75 |
| Dec 30, 2024 | 412.40 | 5.85 | 1.44% | 406.55 | 414.37 | 404.33 |
| Dec 27, 2024 | 414.75 | 1.35 | 0.33% | 413.40 | 417.33 | 409.13 |
| Dec 26, 2024 | 415.71 | 6.75 | 1.65% | 408.96 | 417.66 | 406.54 |
| Dec 24, 2024 | 412.06 | 3.04 | 0.74% | 409.02 | 413.86 | 406.13 |
| Dec 23, 2024 | 411.67 | 1.77 | 0.43% | 409.90 | 413.27 | 407.16 |
| Dec 20, 2024 | 411.05 | 5.16 | 1.27% | 405.89 | 417.66 | 401.10 |
| Dec 19, 2024 | 408.88 | 0.57 | 0.14% | 408.31 | 414.12 | 406.33 |
| Dec 18, 2024 | 410.08 | -13.17 | -3.11% | 423.25 | 427.33 | 408.46 |
| Dec 17, 2024 | 425.96 | -4.03 | -0.94% | 429.99 | 438.86 | 425.96 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
IDEXX Labs Company profile
About IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services for the companion animal veterinary, livestock and poultry, dairy and water testing markets. It also sells a line of portable electrolytes and blood gas analyzers used in the human diagnostics market. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment CAG develops, designs, manufactures, and distributes products and performs services for veterinarians and the biomedical analytics market, primarily related to diagnostics and information management. The Water segment develops, designs, manufactures, and distributes a range of products used in the detection of various microbiological parameters in water. The LPD segment develops, designs, manufactures, and distributes diagnostic tests and related instrumentation and performs services that are used to manage the health status of livestock and poultry.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, IDEXX Laboratories, Inc. revenues increased 19% to $3.22B. Net income increased 28% to $744.8M. Revenues reflect CAG segment increase of 21% to $5.42B, Water segment increase of 14% to $146.5M, United States segment increase of 18% to $2B, Canada segment increase of 30% to $139.7M, Germany segment increase of 23% to $146.8M. Net income benefited from CAG segment income increase of 43% to $824M.
Equity composition
Common Stock $.10 Par, 06/11, 120M auth., 98,835,000 issd., less 42,004,000 shs. in Treas. @ $1.16B. Insiders control approx.1.09%. IPO: 4/92, 1.5M shares @ $20.50 by Lehman Brothers. PO: 10/95, 4.6M shares @ $35 by Cowen & Company. 11/07, 6/95 & 10/93, 2-for-1 stock splits. 06/15, 2-for-1, Stock Split.
| Industry: | Veterinary Medical Equipment & Supplies |
One Idexx Drive
WESTBROOK
MAINE 04092-2041
US
News
Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025
Euro forecast: third party data roundup
In 2024, the euro’s outlook appeared more stable. Read on for our 2025 and beyond insights.
12:40, 31 December 2024
Pi Network coin price prediction: Third party price target
Discover the Pi Network coin price predictions for 2025 onward, with analyst outlooks, price targets and CFDs trading strategies on Capital.com
13:51, 13 December 2024
Projected US interest rates in 5 years: Third party round up
As the US central bank starts its cutting cycle, what are the projected interest rates in 5 years?
14:28, 12 December 2024
Projected UK interest rates in 5 years
Bank of England (BoE) cut rates for the first time in August 2024, with further easing expected in the coming months. But how low are rates likely to go?
11:20, 12 December 2024
Dogecoin (DOGE) price prediction 2025-2030: Could Dogecoin reach $1? - Third party price target
We look at the meme coin’s price performance and the latest DOGE price predictions
08:37, 12 December 2024
Gold price predictions for the next five years: Third party data round up
Explore the future of gold prices and whether the yellow metal will continue its upward trend in the coming years.
09:13, 6 December 2024People also watch
Still looking for a broker you can trust?
Join the 660,000+ traders worldwide that chose to trade with Capital.com